Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2025-12-24 @ 5:42 PM
NCT ID:
NCT00640068
Eligibility Criteria:
Inclusion Criteria:
(Patient must meet one criteria)
* Patient has had a CCTA examination ordered by a referring physician at a participating site.
* Patient is a self referral.
Exclusion Criteria:
Clinical contraindications to CCTA are present as determined by attending physician or staff, including but not limited to:
* Pregnancy or potential pregnancy.
* Renal failure or dysfunction.
* Inability to receive beta blockers.
* Allergy to iodinated contrast without prior premedication.
* Unwillingness to participate.
* Inability to read or understand Patient Information Sheet.
* Age less than 18 years without parent or guardian's evaluation of Patient Information Sheet. Underage and other vulnerable populations are included as the CQI process is intended to detect and correct adverse consequences of CCTA, e.g., excessive radiation, and protect such patients.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT00640068
Study Brief:
Protocol Section:
NCT00640068